Literature DB >> 25613542

The immune system in the normal endometrium and implications for endometrial cancer development.

A Vanderstraeten1, S Tuyaerts2, F Amant3.   

Abstract

Although described for the first time some decades ago, the contribution of the immune system to the establishment of tumors has not been extensively pursued for a long time. Over the last decade, however, more and more evidence has been accumulating concerning the role the immune system plays in tumor development and progression and its possible role in patient prognosis. In addition, interest is growing in preclinical and clinical research concerning the use of the immune system in the treatment of cancer. Immunotherapy for gynecological cancers in general, and for endometrial cancer in particular, is still in its infancy. Only a small number of studies, with varying success rates, have been published. Here, we provide a concise overview of the literature available on the role of the immune system in the normal endometrium and in endometrial cancer, in addition to the possible implications for future immunotherapeutic studies.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Endometrium; Immune system; Immunotherapy

Mesh:

Year:  2015        PMID: 25613542     DOI: 10.1016/j.jri.2014.12.006

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  24 in total

1.  Increased frequency of regulatory T cells in the peripheral blood of patients with endometrioid adenocarcinoma.

Authors:  Li Li; Yinghua Li; Zhuomin Yin; Jing Zhu; Dingding Yan; Hanmei Lou
Journal:  Oncol Lett       Date:  2019-06-07       Impact factor: 2.967

Review 2.  Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.

Authors:  Dmitriy Zamarin; Amir A Jazaeri
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

Review 3.  Immune check-point in endometrial cancer.

Authors:  Francesca De Felice; Claudia Marchetti; Vincenzo Tombolini; P Benedetti Panici
Journal:  Int J Clin Oncol       Date:  2019-05-02       Impact factor: 3.402

4.  A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.

Authors:  Blendi Ura; Valeria Capaci; Michelangelo Aloisio; Giovanni Di Lorenzo; Federico Romano; Giuseppe Ricci; Lorenzo Monasta
Journal:  Biomedicines       Date:  2022-08-02

5.  Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities.

Authors:  Alessandro Rizzo
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

6.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 7.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16

8.  Identification of molecular subtypes premised on the characteristics of immune infiltration of endometrial cancer.

Authors:  Cong Liu; Yan Zhang; Chen Hang
Journal:  Ann Transl Med       Date:  2022-03

9.  Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.

Authors:  Pu Cheng; Jiong Ma; Xia Zheng; Chunxia Zhou; Xuejun Chen
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

Review 10.  Building a stem cell-based primate uterus.

Authors:  Sophie Bergmann; Magdalena Schindler; Clara Munger; Christopher A Penfold; Thorsten E Boroviak
Journal:  Commun Biol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.